Ferguson Wellman Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $165M | Buy |
656,778
+6,367
| +1% | +$1.37M | 2.02% | 11 |
|
|
2026
Q1 | $141M | Sell |
650,411
-87
| -0% | -$19.3K | 1.93% | 12 |
|
|
2025
Q4 | $149M | Buy |
650,498
+2,813
| +0.4% | +$641K | 2.38% | 8 |
|
|
2025
Q3 | $150M | Buy |
647,685
+3,260
| +0.5% | +$664K | 2.43% | 7 |
|
|
2025
Q2 | $120M | Buy |
644,425
+5,132
| +0.8% | +$954K | 2.11% | 11 |
|
|
2025
Q1 | $134M | Buy |
639,293
+11,139
| +2% | +$2.17M | 2.6% | 7 |
|
|
2024
Q4 | $112M | Sell |
628,154
-5,592
| -0.9% | -$1.03M | 2.12% | 9 |
|
|
2024
Q3 | $125M | Sell |
633,746
-2,899
| -0.5% | -$541K | 2.42% | 8 |
|
|
2024
Q2 | $109M | Sell |
636,645
-15,173
| -2% | -$2.51M | 2.22% | 9 |
|
|
2024
Q1 | $119M | Buy |
651,818
+102,399
| +19% | +$17.6M | 2.42% | 7 |
|
|
2023
Q4 | $85.1M | Buy |
549,419
+528
| +0.1% | +$77K | 1.91% | 12 |
|
|
2023
Q3 | $81.8M | Sell |
548,891
-42,976
| -7% | -$6.31M | 2% | 10 |
|
|
2023
Q2 | $79.7M | Sell |
591,867
-161
| -0% | -$23.6K | 1.87% | 11 |
|
|
2023
Q1 | $94.4M | Sell |
592,028
-6,621
| -1% | -$1.01M | 2.37% | 6 |
|
|
2022
Q4 | $96.7M | Buy |
598,649
+278,773
| +87% | +$42.7M | 2.52% | 7 |
|
|
2022
Q3 | $42.9M | Sell |
319,876
-73,875
| -19% | -$10.6M | 1.68% | 13 |
|
|
2022
Q2 | $60.3M | Sell |
393,751
-98,180
| -20% | -$15M | 2.24% | 5 |
|
|
2022
Q1 | $79.7M | Sell |
491,931
-7,456
| -1% | -$1.08M | 2.51% | 5 |
|
|
2021
Q4 | $67.6M | Buy |
499,387
+13,049
| +3% | +$1.54M | 1.97% | 8 |
|
|
2021
Q3 | $52.5M | Buy |
486,338
+4,070
| +0.8% | +$465K | 1.69% | 11 |
|
|
2021
Q2 | $54.3M | Sell |
482,268
-10,397
| -2% | -$1.17M | 1.77% | 12 |
|
|
2021
Q1 | $53.3M | Sell |
492,665
-292,648
| -37% | -$31.3M | 1.85% | 10 |
|
|
2020
Q4 | $84.1M | Buy |
785,313
+9,228
| +1% | +$887K | 2.06% | 8 |
|
|
2020
Q3 | $68M | Buy |
776,085
+112,673
| +17% | +$10.6M | 1.87% | 10 |
|
|
2020
Q2 | $65.1M | Buy |
663,412
+11,561
| +2% | +$1.02M | 1.99% | 9 |
|
|
2020
Q1 | $49.7M | Buy |
651,851
+112,726
| +21% | +$9.6M | 1.86% | 12 |
|
|
2019
Q4 | $47.7M | Buy |
539,125
+9,714
| +2% | +$806K | 1.41% | 16 |
|
|
2019
Q3 | $40.1M | Buy |
529,411
+39,847
| +8% | +$2.73M | 1.28% | 21 |
|
|
2019
Q2 | $35.6M | Buy |
489,564
+212,961
| +77% | +$16.7M | 1.18% | 24 |
|
|
2019
Q1 | $22.3M | Sell |
276,603
-536,494
| -66% | -$43.9M | 0.76% | 41 |
|
|
2018
Q4 | $75M | Sell |
813,097
-21,235
| -3% | -$1.87M | 2.88% | 5 |
|
|
2018
Q3 | $78.9M | Buy |
834,332
+135,551
| +19% | +$12.9M | 2.59% | 5 |
|
|
2018
Q2 | $64.7M | Buy |
698,781
+6,875
| +1% | +$671K | 2.26% | 6 |
|
|
2018
Q1 | $65.5M | Sell |
691,906
-6,873
| -1% | -$755K | 2.32% | 5 |
|
|
2017
Q4 | $67.6M | Buy |
698,779
+2,161
| +0.3% | +$204K | 2.33% | 3 |
|
|
2017
Q3 | $61.9M | Sell |
696,618
-55,132
| -7% | -$4.2M | 2.24% | 4 |
|
|
2017
Q2 | $54.5M | Buy |
751,750
+58,554
| +8% | +$3.94M | 2.05% | 5 |
|
|
2017
Q1 | $45.2M | Buy |
693,196
+8,510
| +1% | +$535K | 1.74% | 9 |
|
|
2016
Q4 | $42.9M | Sell |
684,686
-3,400
| -0.5% | -$208K | 1.75% | 9 |
|
|
2016
Q3 | $43.4M | Sell |
688,086
-72,727
| -10% | -$4.71M | 1.86% | 11 |
|
|
2016
Q2 | $47.1M | Buy |
760,813
+115,764
| +18% | +$7.05M | 1.98% | 8 |
|
|
2016
Q1 | $36.8M | Buy |
645,049
+5,586
| +0.9% | +$311K | 1.57% | 14 |
|
|
2015
Q4 | $37.9M | Buy |
639,463
+68,354
| +12% | +$3.94M | 1.56% | 13 |
|
|
2015
Q3 | $31.1M | Sell |
571,109
-14,783
| -3% | -$962K | 1.38% | 17 |
|
|
2015
Q2 | $39.4M | Sell |
585,892
-11,533
| -2% | -$753K | 1.63% | 9 |
|
|
2015
Q1 | $35M | Sell |
597,425
-212,771
| -26% | -$12.9M | 1.44% | 16 |
|
|
2014
Q4 | $53M | Buy |
810,196
+26,805
| +3% | +$1.69M | 2.13% | 2 |
|
|
2014
Q3 | $45.2M | Buy |
783,391
+296,508
| +61% | +$16.5M | 1.93% | 5 |
|
|
2014
Q2 | $27.5M | Sell |
486,883
-84,595
| -15% | -$4.44M | 1.16% | 26 |
|
|
2014
Q1 | $29.4M | Sell |
571,478
-2,135
| -0.4% | -$108K | 1.31% | 22 |
|
|
2013
Q4 | $30.3M | Sell |
573,613
-170,935
| -23% | -$8.4M | 1.37% | 18 |
|
|
2013
Q3 | $33.3M | Buy |
744,548
+202,339
| +37% | +$8.97M | 1.65% | 8 |
|
|
2013
Q2 | $22.4M | Buy |
+542,209
| New | +$23.7M | 1.73% | 22 |
|
Other funds holding ABBV
ATO
HCM
AAMU
AAIS
HPC
Ferguson Wellman Capital Management's ABBV Position: Q2 2026 in Review
Ferguson Wellman Capital Management increased its AbbVie (ABBV) stake by 0.98% in Q2 2026, buying an estimated $1.37M and bringing the position to 656,778 shares worth $165M. The position accounts for 2.02% of the portfolio, ranked #11.
Ferguson Wellman Capital Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 1,580 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Ferguson Wellman Capital Management held 656,778 shares of AbbVie worth $165M as of Q2 2026.
- Ferguson Wellman Capital Management bought 6,367 AbbVie shares in Q2 2026, an estimated $1.37M.
- AbbVie made up 2.02% of Ferguson Wellman Capital Management's portfolio in Q2 2026, its #11 holding.
- Ferguson Wellman Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 1,580 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Ferguson Wellman Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.